Taylor Sandison
2021
In 2021, Taylor Sandison earned a total compensation of $1.2M as Chief Medical Officer at Cidara Therapeutics, a 46% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $149,100 |
|---|---|
| Option Awards | $219,356 |
| Salary | $445,900 |
| Stock Awards | $337,344 |
| Other | $2,900 |
| Total | $1,154,600 |
Sandison received $445.9K in salary, accounting for 39% of the total pay in 2021.
Sandison also received $149.1K in non-equity incentive plan, $219.4K in option awards, $337.3K in stock awards and $2.9K in other compensation.
Rankings
In 2021, Taylor Sandison's compensation ranked 8,276th out of 12,415 executives tracked by ExecPay. In other words, Sandison earned more than 33.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,276 out of 12,415 | 33rd |
Division Manufacturing | 3,663 out of 5,505 | 34th |
Major group Chemicals And Allied Products | 1,628 out of 2,375 | 32nd |
Industry group Drugs | 1,448 out of 2,096 | 31st |
Industry Biological Products, Except Diagnostic Substances | 322 out of 449 | 28th |
Source: SEC filing on April 29, 2022.
Sandison's colleagues
We found two more compensation records of executives who worked with Taylor Sandison at Cidara Therapeutics in 2021.
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019